Vaccinated people have lower levels of inflammatory markers after COVID-19 infection

In one of the largest studies of its kind, researchers provide answers to whether COVID-19 vaccinations reduce sickness and mortality following infection with SARS-CoV-2.

Coherus sells Sandoz its Lucentis biosimilar for $170M to focus on oncology assets

Coherus BioSciences is selling its FDA-approved ophthalmology biosimilar Cimerli — a copycat version of Roche’s Lucentis — to Sandoz for $170 million in cash to

January 23, 2024

Revolutionary AI predicts aging and disease from DNA patterns

Researchers developed CpGPT, a novel foundation model for DNA methylation analysis that captures sequence, positional, and epigenetic context to predict aging and disease risks. This

November 12, 2024

Disruptions loom for telehealth providers and patients as Congress inches closer to deadline

Around November, Kivo Health, a telehealth provider of pulmonary rehabilitation services, will need to start warning older patients that their sessions may not be covered

July 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.